Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Products
  • Duloxetine Delayed-Release Capsules
Where it was sold

PA, OH, PR

States: Ohio, Pennsylvania, Puerto Rico

Units affected
23,490 bottles
About this recall
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories